Fig. 10

Analysis of the diagnostic value of the signature of the five differentially expressed genes (DEG) in tissues of hepatocellular carcinoma (HCC) patients. (A) Using tissue chips, HCC samples were divided into low-risk and high-risk categories. Survival time and survival status of each patient with HCC in tissue chips (top). Expression levels of TRIM36, CYP26B1, PAGE1, CDK5R2, and DCAF8L1 in HCC tissues from patients with high-risk and low-risk scores in tissue chips (bottom); (B) Analysis of Kaplan-Meier plots of overall survival rates for patients with HCC according to their risk scores; (C) The receiver operating characteristic curves show the diagnostic value of the risk model for patients with HCC at 1-, 3-, and 5-years after diagnosis; (D) Histologic grade, tumor size, T stage, N stage, alpha-fetoprotein (AFP), and risk score were used to construct the nomogram. (E) A flowchart to illustrate our research